Screener

Deferred Revenue

Name: 10x Genomics, Inc. Deferred Revenue by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

10x Genomics, Inc.·Products & Services·1 segment·Rolls up to Deferred Revenue

Breakdown

Segment	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Products and Services, Excluding Grant Revenue	$16.4M	$17.8M	$20.9M	$21.4M	$22.1M	$23.9M	$24.3M	$23.6M
Total	$16.44M	$17.76M	$20.95M	$21.45M	$22.14M	$23.9M	$24.34M	$23.61M

Products and Services, Excluding Grant RevenueView metric